Press Releases Ocugen, Inc. Börse Stuttgart

Equities

2H51

US67577C1053

Real-time Estimate Tradegate Other stock markets 07:11:31 17/07/2024 pm IST			5-day change	1st Jan Change
1.732 ^EUR	-1.70%		+7.50%	+220.95%

01/07	Ocugen, Inc.(NasdaqCM:OCGN) added to Russell Small Cap Completeness Index	CI
01/07	Ocugen, Inc.(NasdaqCM:OCGN) added to Russell Microcap Growth Index	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Kaival Brands Innovations Group (NASDAQ: KAVL) Secures $6M in Public Offering, Stock Surges Watch VTAK, OCGN, DYAI, INBS	27/06	AQ
Ocugen Announces Data and Safety Monitoring Board Approves Enrollment in High Dose Cohort 3 in GARDian Study for Stargardt Disease	21/06	GL
Ocugen, Inc. Announces First Patient Dosed in Phase 3 liMeliGhT Clinical Trial for OCU400—First Gene Therapy in Phase 3 with a Broad Retinitis Pigmentosa Indication	20/06	GL
Modifier gene therapy – clinical development and manufacturing considerations	13/06	AQ
OCGN DEADLINE TODAY: ROSEN, THE FIRST FILING FIRM, Encourages Ocugen, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important June 10 Deadline in Securities Class Action First Filed by the Firm – OCGN	10/06	BU
DEADLINE TODAY: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact the Firm	10/06	BU
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit	08/06	PR
MONDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact the Firm	07/06	BU
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit	07/06	PR
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen	06/06	PR
FINAL DEADLINE NEXT WEEK: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses In Excess of $250,000 to Contact the Firm	04/06	PR
OCGN Investors Have Opportunity to Lead Ocugen, Inc. Securities Fraud Lawsuit	04/06	PR
OCGN DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important June 10 Deadline in Securities Class Action First Filed by the Firm - OCGN	04/06	PR
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ocugen	31/05	PR
Data and Safety Monitoring Board Approves Simultaneous Enrollment in Cohort 3 and Phase 2 Initiation in OCU410 ArMaDa study for Geographic Atrophy	31/05	GL
Pomerantz Law Firm Announces the Filing of a Class Action Against Ocugen, Inc. - OCGN	30/05	PR
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important June 10 Deadline in Securities Class Action First Filed by the Firm - OCGN	30/05	NE
OCUGEN SET TO JOIN RUSSELL 3000 INDEX EFFECTIVE JUNE 28, 2024	29/05	AQ
Ocugen to Present at BIO International Convention 2024	29/05	GL
Ocugen Set to Join Russell 3000® Index Effective June 28, 2024	28/05	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Ocugen, Inc. Börse Stuttgart

Equities

2H51

US67577C1053

Press Releases

Filters